Cite
Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials.
MLA
Owens, David R., et al. “Efficacy and Safety of Basal Insulin Glargine 12 and 24 Weeks after Initiation in Persons with Type 2 Diabetes: A Pooled Analysis of Data from Treatment Arms of 15 Treat-to-Target Randomised Controlled Trials.” Diabetes Research & Clinical Practice, vol. 106, no. 2, Nov. 2014, pp. 264–74. EBSCOhost, https://doi.org/10.1016/j.diabres.2014.08.003.
APA
Owens, D. R., Traylor, L., Dain, M.-P., & Landgraf, W. (2014). Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials. Diabetes Research & Clinical Practice, 106(2), 264–274. https://doi.org/10.1016/j.diabres.2014.08.003
Chicago
Owens, David R., Louise Traylor, Marie-Paule Dain, and Wolfgang Landgraf. 2014. “Efficacy and Safety of Basal Insulin Glargine 12 and 24 Weeks after Initiation in Persons with Type 2 Diabetes: A Pooled Analysis of Data from Treatment Arms of 15 Treat-to-Target Randomised Controlled Trials.” Diabetes Research & Clinical Practice 106 (2): 264–74. doi:10.1016/j.diabres.2014.08.003.